This clinical trial studies genetic counseling using an artificial intelligence program (ChatBot) in women with stage 0-III breast cancer who do not currently meet National Comprehensive Cancer Network (NCCN) criteria for genetic testing. Offering genetic counseling and genetic testing to all women recently diagnosed with breast cancer may produce a shortage of genetic counselors. Artificial intelligence (ChatBot) may assist in the genetic counseling process. This study may help researchers better understand the uptake and impact of genetic testing and gain a better understanding for the clinical implication for offering genetic testing for patients recently diagnosed with breast cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04354675.
PRIMARY OBJECTIVES:
I. Determine up-take of testing for those who do not meet NCCN guidelines for genetic testing.
II. Assess overall patient satisfaction and comprehension in both groups.
SECONDARY OBJECTIVES:
I. Assess mutation rate in the overall cohort.
II. Identify reasons for not pursuing genetic testing.
III. Identify any specific areas of improvement in satisfaction and comprehension.
IV. Assess the impact of genetic testing on Time to Treatment in this cohort.
V. Develop workflow for offering genetic testing, providing pre-test genetic counseling, ordering testing, and delivering results.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive genetics counseling using ChatBot.
GROUP II: Patients receive genetics counseling with a genetic counselor.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationCase Comprehensive Cancer Center
Principal InvestigatorZahraa AlHilli
